Vysioneer’s Collaboration with Pfizer Oncology Highlighted in Washington Post Live Interview

We’re honored that Jeffrey Legos, Chief Oncology Officer at Pfizer Oncology, highlighted our collaboration during his Washington Post Live interview.

“Lastly, we are deploying it into our clinical trials as an opportunity to look at the design, the efficiency and the effectiveness of our clinical trials. And in particular, collaborating with companies like Vysioneer in order to enhance early decision-making by using radiographic information to better understand how a patient’s disease is progressing or responding to therapy.”

At Vysioneer, this belief drives our work every day. Our AI platform, VTrial, is built to accelerate clinical trials and help deliver life-saving therapies to patients as quickly as possible.

Watch the full interview here: https://www.youtube.com/live/uC_DHoxJAxE?t=1079s